| Host: |
Rabbit |
| Applications: |
WB/IHC |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-E3 ubiquitin-protein ligase RNF103 (243-293 aa) is suitable for use in Western Blot and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC-P 1:50-300 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
RNF103 |
| Gene ID: |
7844 |
| Uniprot ID: |
RN103_HUMAN |
| Immunogen Region: |
243-293 aa |
| Specificity: |
This antibody detects endogenous levels of RN103 at Human/Mouse/Rat |
| Immunogen: |
Synthesized peptide derived from the human RN103 at the amino acid range 243-293 |
| Function | Acts as an E2-dependent E3 ubiquitin-protein ligase, probably involved in the ER-associated protein degradation pathway. |
| Protein Name | E3 Ubiquitin-Protein Ligase Rnf103Kf-1Hkf-1Ring Finger Protein 103Ring-Type E3 Ubiquitin Transferase Rnf103Zinc Finger Protein 103 HomologZfp-103 |
| Database Links | Reactome: R-HSA-901032 |
| Cellular Localisation | Endoplasmic Reticulum MembraneMulti-Pass Membrane Protein |
| Alternative Antibody Names | Anti-E3 Ubiquitin-Protein Ligase Rnf103 antibodyAnti-Kf-1 antibodyAnti-Hkf-1 antibodyAnti-Ring Finger Protein 103 antibodyAnti-Ring-Type E3 Ubiquitin Transferase Rnf103 antibodyAnti-Zinc Finger Protein 103 Homolog antibodyAnti-Zfp-103 antibodyAnti-RNF103 antibodyAnti-ZFP103 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
